IN VITRO TOCOLYTIC ACTIVITY OF 3-BENZAMIDO-1-(4-(2-METHOXYPHENYL)-PIPERAZIN-1-YL)-PROPYL-2-ISOPROPYLCARBOXAMIDE

被引:0
|
作者
Lucky, Okunrobo O. [1 ]
Omonkhelin, Owolabi J. [2 ,3 ]
机构
[1] Univ Benin, Dept Pharmaceut Chem, Fac Pharm, Benin, Nigeria
[2] Univ Benin, Dept Pharmacol, Fac Pharm, Benin, Nigeria
[3] Univ Benin, Dept Toxicol, Fac Pharm, Benin, Nigeria
关键词
Tocolytic activity; preterm labor; antagonist; carboxamide; synthesis; PRETERM LABOR;
D O I
10.1007/s11094-009-0237-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis of 3-benzamido-1-(4-(2-methoxyphenyl) piperazin-1-yl)-propyl-2-isopropylcarboxamide (BPC) was accomplished by treating N-3-(4-(2-methoxyphenyl)piperazin-1-yl)-propyl-2-isopropylphthalimide with isopropylamine in dimethylformamide at room temperature. The compound was characterized spectroscopically. At concentrations of 0.05 and 0.1 mg/ml, 3-benzamido-1-(4-(2-methoxyphenyl)piperazin-1-yl)-propyl-2-isopropylcarboxamide (BPC) produced a significant inhibition of oxytocin (p < 0.05) and acetylcholine (p < 0.0001) induced contractions of the uterine smooth muscle in non-pregnant rats in a dose-dependent manner. From the results obtained it may be inferred that this compound is probably acting via muscarinic receptors.
引用
收藏
页码:16 / 18
页数:3
相关论文
共 50 条
  • [21] Bis[4-(2-methyl-2-propenyl)piperazin-1-yl]-methane
    Ricken, S
    Schürmann, M
    Preut, H
    Eilbracht, P
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O1435 - O1436
  • [22] 2-[4-(2-Hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
    Gao, F
    Yin, CX
    Yang, P
    Xue, G
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2004, 60 : O1328 - O1329
  • [23] SYNTHESES OF 1-ARYL-2-(4-[4-(3-OXOBUTYL)PHENYL]PIPERAZIN-1-YL)ETHANONES
    GOMEZPARRA, V
    SANCHEZ, F
    YAGUE, C
    ARCHIV DER PHARMAZIE, 1986, 319 (06) : 552 - 558
  • [24] (E)-1-{4-[Bis(4-methoxyphenyl)methyl]-piperazin-1-yl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-en-1-one
    Zhong, Yan
    Zhang, Xiao-Ping
    Wu, Bin
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1259 - +
  • [25] 3-Chloro-6-{4-[3-(4-chlorophenoxy)propyl]piperazin-1-yl}pyridazine
    Wang, Hongliang
    Xiao, Junhai
    Zhang, Xian
    Sun, Tiemin
    Li, Song
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O716 - U5864
  • [26] 2-Chloro-1-[4-(2,4-difluorobenzyl)piperazin-1-yl]ethanone
    Zhang, Bo
    Damu, Guri L. V.
    Lv, Jing-Song
    Zhou, Cheng-He
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2012, 68 : O70 - +
  • [27] N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists
    Newman, Amy Hauck
    Grundt, Peter
    Cyriac, George
    Deschamps, Jeffrey R.
    Taylor, Michelle
    Kumar, Rakesh
    Ho, David
    Luedtke, Robert R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2559 - 2570
  • [28] Crystal structure of 4-(2-methoxyphenyl)piperazin-1-ium 3,5-dintrosalicylate
    Subha, Veerappan
    Seethalakshmi, Thangaraj
    Balakrishnan, Thangavelu
    Percino, M. Judith
    Venkatesan, Perumal
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2022, 78 : 774 - +
  • [29] Synthesis of [123I] 4-iodo-N-(4-[4-(2-methoxyphenyl) piperazin-1-yl]butyl)-benzamide:: A possible spect tracer for the dopamine D3 receptor
    Dumont, F
    De Vos, F
    Verhoeven, E
    Slegers, G
    Dierckx, RA
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 971 - 971
  • [30] 3-Chloro-6-[4-(2-pyridyl)piperazin-1-yl]pyridazine
    Arslan, Hakan
    Utku, Semra
    Hardcastle, Kenneth I.
    Goekce, Mehtap
    Lense, Sheri
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O35 - U1392